Atlassian (TEAM) Stock Forecast & Price Target $85.42 +3.24 (+3.94%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$84.94 -0.48 (-0.56%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atlassian - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 28 Analyst RatingsSell1Hold5Buy22 Based on 28 Wall Street analysts who have issued ratings for Atlassian in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 1 has given a sell rating, 5 have given a hold rating, 21 have given a buy rating, and 1 has given a strong buy rating for TEAM. Consensus Price Target $145.6370.49% Upside According to the 28 analysts' twelve-month price targets for Atlassian, the average price target is $145.63. The highest price target for TEAM is $295.00, while the lowest price target for TEAM is $95.00. The average price target represents a forecasted upside of 70.49% from the current price of $85.42. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for TEAM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Atlassian and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEAM Analyst Ratings Over TimeTypeCurrent Forecast5/23/25 to 5/23/261 Month Ago4/23/25 to 4/23/263 Months Ago2/22/25 to 2/22/261 Year Ago5/23/24 to 5/23/25Strong Buy1 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy21 Buy rating(s)19 Buy rating(s)20 Buy rating(s)19 Buy rating(s)Hold5 Hold rating(s)6 Hold rating(s)5 Hold rating(s)4 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)2 Sell rating(s)0 Sell rating(s)Consensus Price Target$145.63$155.11$189.32$285.29Forecasted Upside70.49% Upside129.39% Upside149.17% Upside37.94% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy TEAM Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History TEAM Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Atlassian Stock vs. The CompetitionTypeAtlassianComputer and Technology CompaniesBroader MarketConsensus Rating Score 2.79 2.29 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside70.49% Upside156.58% Upside15.09% UpsideNews Sentiment RatingPositive NewsSee Recent TEAM NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/11/2026 Oppenheimer3 of 5 starsIttai Kidron1 of 5 starsBoost TargetOutperform$100.00 ➝ $110.00+20.09%5/7/2026 Barclays3 of 5 starsRaimo Lenschow2 of 5 starsBoost TargetOverweight$106.00 ➝ $112.00+26.13%5/7/2026 BTIG Research2 of 5 starsAllan VerkhovskiNot RatedBoost TargetBuy$120.00 ➝ $130.00+46.40%5/6/2026 Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Strong-Buy5/1/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDerrick WoodSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetHold$85.00 ➝ $105.00+25.02%5/1/2026 Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRob OliverSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet Target$120.00+41.04%5/1/2026 Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOutperform$295.00+251.24%5/1/2026 Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJoel FishbeinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$90.00 ➝ $100.00+19.07%5/1/2026 Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingThomas BlakeySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$98.00 ➝ $107.00+27.40%5/1/2026 Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Set Target$130.00+51.32% Get the Latest News and Ratings for TEAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atlassian and its competitors with MarketBeat's FREE daily newsletter. 5/1/2026 CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingFatima BoolaniSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$160.00 ➝ $110.00+60.37%5/1/2026 UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKarl KeirsteadSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetNeutral$105.00 ➝ $95.00+6.89%5/1/2026 Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRob OwensSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$200.00 ➝ $175.00+106.60%5/1/2026 BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOutperform$130.00 ➝ $105.00+53.08%4/20/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingSell (E+)4/16/2026 Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKeith WeissSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$290.00 ➝ $120.00+81.82%4/15/2026 Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid HynesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$185.00 ➝ $150.00+151.21%4/14/2026 MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingGreg MoskowitzSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOutperform$185.00 ➝ $145.00+136.54%4/9/2026 GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Set Target$115.00+101.69%4/1/2026 KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJason CelinoSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$170.00 ➝ $130.00+86.83%3/17/2026 Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRyan MacWilliamsSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$155.00 ➝ $120.00+57.54%3/16/2026 BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Initiated CoverageOutperform$95.00+26.31%3/12/2026 Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAlex ZukinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform$100.00+36.35%2/6/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Set Target$150.00+52.42%11/3/2025 Macquarie InfrastructureSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSteve KoenigSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOutperform$250.00 ➝ $240.00+36.30%10/31/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKash RanganSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy$260.00+61.82%9/23/2025 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKoji IkedaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingInitiated CoverageNeutral$200.00+17.21%8/11/2025 StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBrett HuffSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetEqual Weight$221.00 ➝ $202.00+20.20%7/16/2025 Capital One FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingConnor MurphySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$211.00+12.42%1/31/2025 Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick WalravensSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingMarket Perform1/31/2025 William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOutperform1/31/2025 ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingNick AltmannSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetSector Perform$250.00 ➝ $330.00+5.32%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:08 PM ET. Should I Buy Atlassian Stock? TEAM Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, May 21, 2026. Please send any questions or comments about these Atlassian pros and cons to contact@marketbeat.com. Atlassian Bull Case Here are some ways that investors could benefit from investing in Atlassian Co.: The current stock price is around $87.46, which reflects a recent increase of 8.2%, indicating positive market sentiment and potential for further growth. Analysts have issued a majority of positive ratings, with one Strong Buy, twenty-one Buy ratings, and an average price target of approximately $145.63, suggesting significant upside potential. Atlassian Co. has a strong insider ownership of 36.66%, which often indicates confidence from executives in the company's future performance. The company has a diverse product portfolio that includes collaboration and project management tools, catering to a wide range of industries, which can help mitigate risks associated with market fluctuations. Recent analyst upgrades, including a target price increase from various firms, highlight growing confidence in the company's growth trajectory and market position. Atlassian Bear Case Investors should be bearish about investing in Atlassian Co. for these reasons: The company has a negative P/E ratio of -105.37, which may raise concerns about profitability and financial health, as it indicates that the company is currently not generating profits. Atlassian Co. has a current ratio of 0.70, suggesting potential liquidity issues, as it indicates that the company may not have enough short-term assets to cover its short-term liabilities. Recent insider sales, including significant transactions by executives, could signal a lack of confidence in the company's short-term performance or future prospects. The stock has experienced volatility, with a 1-year high of $223.42 and a low of $56.01, indicating potential risks for investors looking for stability. Analyst target price reductions from firms like BMO Capital Markets and Piper Sandler may reflect concerns about the company's growth outlook and competitive positioning. TEAM Forecast - Frequently Asked Questions What is Atlassian's forecast for 2026? According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Atlassian is $145.63, with a high forecast of $295.00 and a low forecast of $95.00. Should I buy or sell Atlassian stock right now? 28 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Atlassian in the last twelve months. There is currently 1 sell rating, 5 hold ratings, 21 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TEAM shares. Does Atlassian's stock price have much upside? According to analysts, Atlassian's stock has a predicted upside of 70.49% based on their 12-month stock forecasts. Has Atlassian been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Atlassian's stock had 2 upgrades and 1 downgrade by analysts. What analysts cover Atlassian? Atlassian has been rated by research analysts at Barclays, BMO Capital Markets, BNP Paribas Exane, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Guggenheim, KeyCorp, Mizuho, Morgan Stanley, Oppenheimer, Piper Sandler, Raymond James Financial, Robert W. Baird, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, Wolfe Research, and Zacks Research in the past 90 days. Do Wall Street analysts like Atlassian more than its competitors? Analysts like Atlassian more than other "computer and technology" companies. The consensus rating for Atlassian is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how TEAM compares to other companies. Stock Forecasts and Research Tools Related Companies GitLab Stock Forecast monday.com Stock Forecast Paylocity Stock Forecast Workday Stock Forecast Dynatrace Stock Forecast HubSpot Stock Forecast Cloudflare Stock Forecast ServiceNow Stock Forecast Procore Technologies Stock Forecast PagerDuty Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Atlassian RecommendationsOppenheimerWall Street ZenBTIG ResearchBarclaysZacks ResearchCitigroupBMO Capital MarketsCantor FitzgeraldPiper SandlerTD CowenUBS GroupTruist FinancialRobert W. BairdSanford C. BernsteinRaymond James Financial This page (NASDAQ:TEAM) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlassian Corporation PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlassian With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
